tm logo
Trademark Search
COBALT

View On IC.GC.CA

COBALT
ABANDONED SECTION 36

on 05 Jun 2024

Last Applicant/ Owned by

CRISPR THERAPEUTICS AG

Baarerstrasse 14CH-6300 ZUG V8

CH

Serial Number

2151330 filed on 02th Nov 2021

Correspondent Address

SUITE 1000, 55 METCALFE STREETP.O. BOX 2999, STATION DOTTAWA

ONTARIO

CA

K1P5Y6

COBALT

Trademark usage description

cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer; gene therapy products, namely, gene transf Read More

Classification Information

Class [005]
Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cancer.

Classification kind code

11

Class [042]
Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development.

Classification kind code

11

Mark Details

Serial Number

2151330

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 16th May 2023		Agent Changed
Submitted for opposition 22
on 27th Feb 2023		Search Recorded
Submitted for opposition 20
on 27th Feb 2023		Examiner's First Report
Submitted for opposition 223
on 27th Feb 2023		Total Provisional Refusal
Submitted for opposition 256
on 03rd Oct 2022		Notification of Possible Opposition Sent
Submitted for opposition 257
on 02th Dec 2021		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 01st Dec 2021		Created
Submitted for opposition 31
on 01st Dec 2021		Formalized
Submitted for opposition 30
on 02th Nov 2021		Filed
Submitted for opposition 228
on 02th Nov 2021		International Registration